Saturday, October 3, 2026

USD/EUR Over 2% Down In The Last 21 Sessions

USD/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.54% for the last 21 sessions. At 00:12 EST on Friday, 14 July, USD/EUR (USDEUR) is $0.89.

USD/EUR's yearly highs and lows, it's 0.067% up from its 52-week low and 15.112% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.52%, a negative 0.17%, and a positive 0.34%, respectively.

USD/EUR's highest amplitude of average volatility was 0.52% (last week), 0.39% (last month), and 0.34% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • According to FXStreet on Wednesday, 12 July, "From our perspective, EUR/USD is still too far from the upper end of our expected Q3 1.0500-1.1250 range (same as Q2) to make a short trade a good risk/reward one, even if we tend to line up on the side of upside CPI surprises. "
  • Eur/usd might well return above the 1.11 mark – commerzbank. According to FXStreet on Wednesday, 12 July, "If any signals from the ECB remain relatively hawkish because the doves on the council continue to receive less attention than the hawks, EUR/USD might well return above the 1.11 mark."
  • Eur/usd technical analysis: bullish momentum ahead - 12 July 2023. According to DailyForex on Wednesday, 12 July, "For four consecutive trading sessions, the price of the EUR/USD currency pair received a strong bullish momentum. ", "It is possible that the lack of fulfillment of market expectations will push the markets to bet on the possibility of only one rise, which will affect yields and the dollar as bets on a decline in movement in September.EUR/USD forecast today:The stability of the price of the EUR/USD currency pair above the psychological resistance 1.1000 will be important for more bulls controlling the trend."
  • Eur/usd maintains strength above 1.1000 as US dollar extends downside ahead of US inflation. According to FXStreet on Wednesday, 12 July, "The EUR/USD pair has confidently shifted above the psychological resistance of 1.1000 in the Asian session. "
  • According to FXStreet on Wednesday, 12 July, "The pair has disconnected from EUR/USD and its own interest differential and, since the start of the year, the best driver explaining CHF appreciation is the contraction in Swiss banks' sight deposits. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com